Internal Medicine, Hematology & Oncology · Brooklyn, NY
NPI
1043240336
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
19 Fayette St
Brooklyn, NY, 11206
Phone (718) 732-4050
Groups this clinician bills Medicare through
Medicare paid, 2024
$710K
162,102 services
Medicare patients, 2024
153
Average age 74
Drug cost, 2024
$5.9M
3,306 prescriptions
Company payments, 2025
$1,711
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Azriel Hirschfeld was code J9263 (injection, oxaliplatin, 0.5 mg), 49,711 times for 41 patients. In total Azriel Hirschfeld billed 162,102 services in 84 codes, and Medicare paid $710K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 49,711 | 41 | $0.02 | $901 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 9,868 | 61 | $0.04 | $353 |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 8,564 | 42 | $0.03 | $243 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,447 | 62 | $0.04 | $178 |
| J9206 Injection, irinotecan, 20 mg | Office | 2,559 | 46 | $0.47 | $1,206 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 2,278 | 47 | $0.86 | $1,969 |
| 96367 Intravenous Infusion, Hydration | Office | 2,200 | 72 | $26.04 | $57K |
| J9190 Injection, fluorouracil, 500 mg | Office | 1,644 | 47 | $0.69 | $1,141 |
| J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 1,195 | 34 | $0.86 | $1,023 |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 1,007 | 27 | $1.54 | $1,556 |
| 99215 Office E&M - Established | Office | 947 | 126 | $152.47 | $144K |
| 96413 Chemotherapy Administration | Office | 853 | 79 | $120.91 | $103K |
| 96417 Chemotherapy Administration | Office | 627 | 63 | $59.57 | $37K |
| 99214 Office E&M - Established | Office | 523 | 100 | $112.20 | $59K |
| 96415 Chemotherapy Administration | Office | 492 | 62 | $25.62 | $13K |
By year: 2022 $679K for 182,670 services; 2023 $738K for 206,798 services; 2024 $710K for 162,102 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 432 | 71 | $8.65 | $3,737 |
| 85025 Blood Count | 237 | 50 | $7.61 | $1,804 |
Medicare prescription drug claims, 2024
In 2024, the drug Azriel Hirschfeld prescribed most often to Medicare patients was Ondansetron Hcl (Ondansetron Hcl/Pf), with 205 prescriptions and refills. In total Azriel Hirschfeld wrote 3,306 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Ondansetron Hcl/Pf | 205 | 205 | 62 | $1,622 |
| Leucovorin Calcium Generic | 196 | 196 | 58 | $16K |
| Irinotecan Hcl Generic | 192 | 192 | 59 | $182K |
| Famotidine Famotidine/Pf | 189 | 189 | 59 | $396 |
| Fluorouracil Generic | 181 | 181 | 51 | $12K |
| Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosp/Pf | 179 | 179 | 60 | $1,739 |
| Oxaliplatin Generic | 140 | 140 | 50 | $193K |
| Gemcitabine Hcl Generic | 140 | 140 | 44 | $17K |
| Pantoprazole Sodium Generic | 93 | 105 | 27 | $626 |
| Anastrozole Generic | 75 | 109 | 12 | $536 |
| Paclitaxel Generic | 69 | 69 | 17 | $6,840 |
| Zirabev Bevacizumab-Bvzr | 68 | 68 | 22 | $576K |
| Carboplatin Generic | 63 | 63 | 18 | $3,602 |
| Creon Lipase/Protease/Amylase | 54 | 57 | 17 | $148K |
| Olanzapine Generic | 50 | 53 | 18 | $465 |
Brand drugs: - claims; generic drugs: 2,510 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Azriel Hirschfeld $1,711 ($1,711 in general payments such as food, travel and fees) from 24 companies. The largest payer was McKesson Specialty Care Distribution, LLC with $245.
| Company | Payments | Amount |
|---|---|---|
| McKesson Specialty Care Distribution, LLC | 1 | $245 |
| GlaxoSmithKline, LLC. GSK | 8 | $186 |
| Janssen Biotech, Inc. JNJ | 8 | $185 |
| Eisai Inc. 4523.T | 15 | $176 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $79.06 |
| pharmaand GmbH | 6 | $72.65 |
| Exelixis Inc. EXEL | 3 | $70.41 |
| Stemline Therapeutics Inc. | 4 | $70.12 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $65.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.